Sven Mahner

Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.

Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer.

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Vitamin D and VDR in Gynecological Cancers-A Systematic Review.

Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders.

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages.

Prostaglandin E receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses.

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas.

The genetic landscape of 87 ovarian germ cell tumors.

[Hallmarks in obstetrics and gynecology].

Histone H3 lysine 9 acetylation is downregulated in GDM Placentas and Calcitriol supplementation enhanced this effect.

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.

Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report.

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.

Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.

Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.

Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients.

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer.

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases.

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.

Sex-specific epigenetic gene activation profiles are differentially modulated in human placentas affected by intrauterine growth restriction.

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis.

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.

The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.

Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia.

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer.

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.

Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individuals.

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.

Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus.

Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer.

Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development.

Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage.

The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.

Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.

Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.

Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRI.

MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.

[Not Available].

Pelvic inlet area is associated with birth mode.

Prostaglandin E2 receptor EP1 expression in vulvar cancer.

Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping.

Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controls.

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro.